Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp Ads (NQ: AMRN )

5.000 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.000
Bid (Size) 4.690 (5)
Ask (Size) 5.250 (2)
Prev. Close 5.000
Today's Range 5.000 - 5.000
52wk Range 3.360 - 9.250
Shares Outstanding 394,764,841
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic Acid (EPA) Presented at the European Atherosclerosis Society (EAS) Congress 2021
Studies support potentially important anti-inflammatory, protein modulation, and cell function effects of icosapent ethyl as known by the brand name VASCEPA® in much of the world and as VAZKEPA in... 
From GlobeNewswire News Releases
Amarin to Present at Two Investor Conferences in June 2021
From GlobeNewswire News Releases

Performance

YTD
-0.60%
-0.60%
1 Month
+15.74%
+15.74%
3 Month
-24.01%
-24.01%
6 Month
-1.77%
-1.77%
1 Year
-27.01%
-27.01%

More News

Read More
Amarin Highlights Multiple Scientific Findings for VASCEPA® (Icosapent Ethyl) and Its Unique Active Ingredient at the American College of Cardiology’s 70th Annual Scientific Session
From GlobeNewswire News Releases
REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented
From GlobeNewswire News Releases
Clinical Data and Other Research Results Regarding VASCEPA® (Icosapent Ethyl) and Its Unique Active Ingredient to Be Presented at the American College of Cardiology’s 70th Annual Scientific Session
From GlobeNewswire News Releases
Amarin Reports First Quarter 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Amarin Announces Planned Retirement of Joseph T. Kennedy, EVP, General Counsel
From GlobeNewswire News Releases
Understanding Amarin Corp's Unusual Options Activity
Tags Market News Options Markets
From Benzinga
PPH's Holdings Imply 14% Gain Potential
Tags ETFs
From ETF Channel
Market Briefing For Tuesday, Jun. 8
Tags Pharma/Biotech Market News Technology
From Blogs - TalkMarkets
Why Amarin Trounced the Market on Tuesday
Tags AMRN Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.